New Delhi: Glenmark Pharmaceuticals announced on Tuesday that it will commence another new Phase 3 clinical trial on a combination of two anti-viral drugs Favipiravir and Umifenovir in hospitalized patients of moderate COVID-19 in India. Glenmark has received approval from the Indian regulator to initiate the study. The combination study which will be called the […]
Copyright © 2024 - Odisha Television Limited All Rights Reserved.
LIVE TV
